Latest Medtech News
Private equity firm KKR has agreed to acquire medical device CDMO Integer Holdings in a $5.7 billion transaction, taking the company private. Under the agreement, Integer shareholders will receive $127 per share, with the deal expected to close by the end of 2026, subject to shareholder and regulatory approvals.
As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like this one. Subscribe to our Industry Insights for weekly coverage.
Integer is one of the world's largest medical device contract development and manufacturing organizations, serving markets including cardiovascular, neuromodulation, and cardiac rhythm management. The company expects the acquisition to provide greater long-term capital and flexibility to support continued growth and innovation.
“This is an exciting milestone for Integer,” said Payman Khales, President and CEO of Integer. “KKR’s deep healthcare expertise, long-term vision, and strategic growth orientation make them the right strategic partner to bring our business into its next chapter.”
“Integer is an exceptional platform with highly differentiated capabilities across a global manufacturing footprint, a track record for quality and reliability, and a talented team operating in attractive, durable end-markets.” shared Max Lin, KKR partner. “We are excited by the opportunity to deploy capital and resources to further advance Integer’s next chapter of growth and innovation.”
